Reaction

Intensive Care reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,377 reports · 38 co-occurring drugs

As of the last recalculation, Intensive Care appears in 1,377 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is IVACAFTOR (PRR 36.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ivacaftor	19	36.6	36.7
Elexacaftor, Tezacaftor, And Ivacaftor	23	28.3	28.4
Cefazolin	11	18.4	18.4
Phytonadione	10	17.9	18.0
Amikacin	19	17.1	17.1
Micafungin Sodium	9	16.1	16.2
Cefazolin Sodium	11	13.9	13.9
Venetoclax	53	13.5	13.5
Riociguat	25	11.8	11.8
Epoprostenol	10	11.6	11.6
Selexipag	18	10.7	10.7
Vincristine Sulfate	20	10.5	10.5
Tranexamic Acid	6	10.2	10.2
Thiotepa	6	9.5	9.5
Axicabtagene Ciloleucel	6	9.2	9.2
Cannabidiol	14	9.1	9.1
Filgrastim	22	9.0	9.0
Valacyclovir	24	8.8	8.8
Blinatumomab	6	8.7	8.7
Granisetron Hydrochloride	6	8.7	8.7
Granisetron	6	8.7	8.7
Instalax Polyethylene Glycol 3350	7	8.6	8.6
Dolutegravir Sodium	5	8.4	8.4
Polyethylene Glycol 400	7	8.4	8.4
Ibrutinib	41	7.9	7.9
Rocuronium Bromide	6	7.7	7.7
Macitentan	34	7.6	7.6
Darbepoetin Alfa	25	7.1	7.1
Fluticasone Propionate And Salmeterol	19	7.0	7.0
Irinotecan Hydrochloride	5	5.9	5.9
Umeclidinium Bromide And Vilanterol Trifenatate	6	5.4	5.4
Brivaracetam	3	5.1	5.1
Canagliflozin	9	4.6	4.6
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	4.3	4.3
Glecaprevir And Pibrentasvir	3	4.1	4.1
Paliperidone Palmitate	6	2.8	2.8
Voxelotor	3	2.0	2.0
Cinacalcet Hydrochloride	6	2.0	2.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.